Brimonidine tartrate - Glaucoma / ocular hypertension

You are here : Home > Formulary Search > Brimonidine tartrate - Glaucoma / ocular hypertension

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue

Formulations :

Eye drops

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

Guidelines BNF SPC

Restrictions / Comments :

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Brimonidine tartrate

Indication :

Glaucoma / ocular hypertension

Group Name :

Keywords :

Intra-ocular pressure

Brand Names Include :

Alphagan

Important Information :

Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Glaucoma / ocular hypertension

Supporting Documents :

Other Indications

Below are listed other indications that Brimonidine tartrate is used to treat.

No records returned.

Other Drugs

Below are listed other drugs that are used to treat Glaucoma / ocular hypertension.

Committee Recommendations (2)

02 Oct 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

22 Jul 19 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Primary care prescribers do not have the necessary equipment or skills to perform ocular pressure readings to make a diagnosis. The APC recomments that this product, when used for treatment of glaucoma, should be considered as BLUE.

Note; the branded product (Alphagan) was considered BLACK at the PCN in May 2017.